484 related articles for article (PubMed ID: 28951211)
1. MicroRNA-194 inhibition improves dietary-induced non-alcoholic fatty liver disease in mice through targeting on FXR.
Nie H; Song C; Wang D; Cui S; Ren T; Cao Z; Liu Q; Chen Z; Chen X; Zhou Y
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3087-3094. PubMed ID: 28951211
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
[TBL] [Abstract][Full Text] [Related]
4. Defective FXR-SHP Regulation in Obesity Aberrantly Increases
Seok S; Sun H; Kim YC; Kemper B; Kemper JK
Diabetes; 2021 Mar; 70(3):733-744. PubMed ID: 33328206
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice.
Zhang ZC; Liu Y; Xiao LL; Li SF; Jiang JH; Zhao Y; Qian SW; Tang QQ; Li X
J Hepatol; 2015 Dec; 63(6):1466-75. PubMed ID: 26272872
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease.
Wang XC; Zhan XR; Li XY; Yu JJ; Liu XM
World J Gastroenterol; 2014 Dec; 20(47):17914-23. PubMed ID: 25548489
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.
Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554
[TBL] [Abstract][Full Text] [Related]
8. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.
Liu J; Tang T; Wang GD; Liu B
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820
[No Abstract] [Full Text] [Related]
9. MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1.
Zhang M; Sun W; Zhou M; Tang Y
Sci Rep; 2017 Nov; 7(1):14493. PubMed ID: 29101357
[TBL] [Abstract][Full Text] [Related]
10. Effects of Farnesoid X Receptor Activation on Arachidonic Acid Metabolism, NF-kB Signaling, and Hepatic Inflammation.
Gai Z; Visentin M; Gui T; Zhao L; Thasler WE; Häusler S; Hartling I; Cremonesi A; Hiller C; Kullak-Ublick GA
Mol Pharmacol; 2018 Aug; 94(2):802-811. PubMed ID: 29743187
[TBL] [Abstract][Full Text] [Related]
11. Schaftoside alleviates HFD-induced hepatic lipid accumulation in mice via upregulating farnesoid X receptor.
Liu M; Zhang G; Wu S; Song M; Wang J; Cai W; Mi S; Liu C
J Ethnopharmacol; 2020 Jun; 255():112776. PubMed ID: 32205261
[TBL] [Abstract][Full Text] [Related]
12. Ganoderma Lucidum Polysaccharide Peptide Alleviates Hepatoteatosis via Modulating Bile Acid Metabolism Dependent on FXR-SHP/FGF.
Zhong D; Xie Z; Huang B; Zhu S; Wang G; Zhou H; Lin S; Lin Z; Yang B
Cell Physiol Biochem; 2018; 49(3):1163-1179. PubMed ID: 30196282
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease.
Xu M; Zheng XM; Jiang F; Qiu WQ
J Cell Biochem; 2018 Jul; 119(7):5864-5874. PubMed ID: 29575055
[TBL] [Abstract][Full Text] [Related]
14. miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21.
Xiao J; Bei Y; Liu J; Dimitrova-Shumkovska J; Kuang D; Zhou Q; Li J; Yang Y; Xiang Y; Wang F; Yang C; Yang W
J Cell Mol Med; 2016 Feb; 20(2):204-16. PubMed ID: 26648452
[TBL] [Abstract][Full Text] [Related]
15. MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator.
Zhuge B; Li G
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):687-692. PubMed ID: 29107687
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of microRNA 146b mimic to hepatocytes by lactosylated PDMAEMA nanoparticles for the treatment of NAFLD.
He S; Guo W; Deng F; Chen K; Jiang Y; Dong M; Peng L; Chen X
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):217-228. PubMed ID: 29560749
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of microRNA-375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non-alcoholic fatty liver disease.
Lei L; Zhou C; Yang X; Li L
Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):819-831. PubMed ID: 29569260
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of miR-181a impairs lipid metabolism by targeting PPARα expression in nonalcoholic fatty liver disease.
Huang R; Duan X; Liu X; Cao H; Wang Y; Fan J; Wang B
Biochem Biophys Res Commun; 2019 Jan; 508(4):1252-1258. PubMed ID: 30558790
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1.
Jiang F; Chen Q; Wang W; Ling Y; Yan Y; Xia P
J Hepatol; 2020 Jan; 72(1):156-166. PubMed ID: 31568800
[TBL] [Abstract][Full Text] [Related]
20. MiR-149 Compromises the Reactions of Liver Cells to Fatty Acid via its Polymorphism and Increases Non-Alcoholic Fatty Liver Disease (NAFLD) Risk by Targeting Methylene Tetrahydrofolate Reductase (MTHFR).
An X; Yang Z; An Z
Med Sci Monit; 2017 May; 23():2299-2307. PubMed ID: 28507283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
